It's official. The drug industry's chief lobbyists raised and spent at least $101.2 million in 2009 on advocacy efforts.
The New Yorker's John Cassidy argues much of what investment bankers do is socially worthless.
It's not the woman who's necessarily controversial. It's just that the date of her infamous bus ride happens to coincide with another meaningful...
Jumo aims to connect people with nonprofits and charitable organizations.
Article | Philanthropy & Corporate Contributions , posted by mason
Cancun climate change summit campaigners say negotiations are a 'complete mess.'
Europe's dash for gas is leading Halliburton, Chevron and Exxon to consider bringing hydraulic fracturing across the Atlantic.
By CSRwire Contributing Writer Francesca Rheannon With the current climate talks in Cancun widely thought unlikely to lead to much progress on climate...
Three business leaders discuss how their companies are implementing policies for the creation and adoption of safer chemicals.
Video | Corporate Social Responsibility , posted by SanfordLewis
Building envelope expert Joe Lstiburek complains LEED wants buildings to be too ventilated. Why? "Because of activists ... say everything in a building...
Global grain production will tumble by 63 million metric tons this year, or 2 percent over all, mainly because of weather-related calamities.